# Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function

> **NCT00717067** · PHASE4 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 30 (actual)

## Conditions studied

- Human Immunodeficiency Virus (HIV) Infection

## Interventions

- **DRUG:** Maraviroc
- **DRUG:** Maraviroc
- **DRUG:** Ritonavir
- **DRUG:** Saquinavir
- **DRUG:** Maraviroc
- **DRUG:** Ritonavir
- **DRUG:** Saquinavir
- **DRUG:** Maraviroc
- **DRUG:** Ritonavir
- **DRUG:** Saquinavir
- **DRUG:** Maraviroc
- **DRUG:** Maraviroc
- **DRUG:** Maraviroc

## Key facts

- **NCT ID:** NCT00717067
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2010-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717067, "Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00717067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*